- The subject has had a documented colonoscopy to the cecum performed by a study-related
physician with adequate preparation resulting in diagnosis and clearance of an
adenomatous polyp(s) within 4 months prior to randomization.
- The subject is willing to abstain from chronic use of all NSAIDs or COX-2 inhibitors
excluding aspirin at cardioprotective doses for the duration of the study.
- The subject has a history of Familial Adenomatous Polyposis or Hereditary
Non-Polyposis Colorectal Cancer.
- The subject has a history of inflammatory bowel disease.